Laboratoires THEA S.A.S agreed to acquire Portfolio of Seven Branded Ophthalmic Products from Akorn Operating Company LLC on January 28, 2022. The transaction is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close in first quarter of 2022. Perella Weinberg Partners acted as financial advisers and Brianne L. Kucerik, David Nigel Griffiths, Frederick S. Green, Jeffrey D. Osterman, Kimberly S. Blanchard, Paul J. Wessel, Romain Ferla, John O'Loughlin, Naomi Munz, Michael C. Naughton of Weil, Gotshal & Manges LLP acted as legal advisor to Laboratoires THEA S.A.S. Russell Leaf, Thomas Mark and Tiffany Lee and Jeffrey Daniel of Willkie Farr & Gallagher LLP acted as legal advisor to Akorn Operating Company LLC. Greenhill & Co., LLC acted as financial advisor to Akorn.

Laboratoires THEA S.A.S completed the acquisition of Portfolio of Seven Branded Ophthalmic Products from Akorn Operating Company LLC on March 8, 2022.